A Lifeline for MS Patients: NHS Approval of Fampridine Signals a Shift in Priorities The National Health Service (NHS) in England has approved the use of fampridine, a medication that can help people with multiple sclerosis (MS) walk.
This breakthrough could mean a return to independence and freedom from debilitating symptoms for thousands of patients.
Fampridine works by boosting nerve signals, allowing those affected by MS to move more easily and live independently.